221 related articles for article (PubMed ID: 22229574)
1. New treatments for emerging cystic fibrosis pathogens other than Pseudomonas.
Waters V
Curr Pharm Des; 2012; 18(5):696-725. PubMed ID: 22229574
[TBL] [Abstract][Full Text] [Related]
2. Pan-Resistant Achromobacter xylosoxidans and Stenotrophomonas maltophilia Infection in Cystic Fibrosis Does Not Reduce Survival After Lung Transplantation.
Lobo LJ; Tulu Z; Aris RM; Noone PG
Transplantation; 2015 Oct; 99(10):2196-202. PubMed ID: 25856407
[TBL] [Abstract][Full Text] [Related]
3. Seasonality of acquisition of respiratory bacterial pathogens in young children with cystic fibrosis.
Psoter KJ; De Roos AJ; Wakefield J; Mayer JD; Rosenfeld M
BMC Infect Dis; 2017 Jun; 17(1):411. PubMed ID: 28599639
[TBL] [Abstract][Full Text] [Related]
4. Changing Epidemiology of the Respiratory Bacteriology of Patients With Cystic Fibrosis.
Salsgiver EL; Fink AK; Knapp EA; LiPuma JJ; Olivier KN; Marshall BC; Saiman L
Chest; 2016 Feb; 149(2):390-400. PubMed ID: 26203598
[TBL] [Abstract][Full Text] [Related]
5. Challenging and emerging pathogens in cystic fibrosis.
de Vrankrijker AM; Wolfs TF; van der Ent CK
Paediatr Respir Rev; 2010 Dec; 11(4):246-54. PubMed ID: 21109184
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiology and management of pulmonary infections in cystic fibrosis.
Gibson RL; Burns JL; Ramsey BW
Am J Respir Crit Care Med; 2003 Oct; 168(8):918-51. PubMed ID: 14555458
[TBL] [Abstract][Full Text] [Related]
7. Quorum Sensing as Antivirulence Target in Cystic Fibrosis Pathogens.
Scoffone VC; Trespidi G; Chiarelli LR; Barbieri G; Buroni S
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013936
[TBL] [Abstract][Full Text] [Related]
8.
Menetrey Q; Sorlin P; Jumas-Bilak E; Chiron R; Dupont C; Marchandin H
Genes (Basel); 2021 Apr; 12(5):. PubMed ID: 33919046
[TBL] [Abstract][Full Text] [Related]
9. Novel Approaches to Multidrug-Resistant Infections in Cystic Fibrosis.
Murray TS; Stanley G; Koff JL
Infect Dis Clin North Am; 2024 Mar; 38(1):149-162. PubMed ID: 38280761
[TBL] [Abstract][Full Text] [Related]
10. Respiratory bacterial infections in cystic fibrosis.
Ciofu O; Hansen CR; Høiby N
Curr Opin Pulm Med; 2013 May; 19(3):251-8. PubMed ID: 23449384
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infections.
Chmiel JF; Aksamit TR; Chotirmall SH; Dasenbrook EC; Elborn JS; LiPuma JJ; Ranganathan SC; Waters VJ; Ratjen FA
Ann Am Thorac Soc; 2014 Sep; 11(7):1120-9. PubMed ID: 25102221
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary infections in patients with cystic fibrosis.
Rajan S; Saiman L
Semin Respir Infect; 2002 Mar; 17(1):47-56. PubMed ID: 11891518
[TBL] [Abstract][Full Text] [Related]
13. Denitrification by cystic fibrosis pathogens - Stenotrophomonas maltophilia is dormant in sputum.
Kolpen M; Kragh KN; Bjarnsholt T; Line L; Hansen CR; Dalbøge CS; Hansen N; Kühl M; Høiby N; Jensen PØ
Int J Med Microbiol; 2015 Jan; 305(1):1-10. PubMed ID: 25441256
[TBL] [Abstract][Full Text] [Related]
14. Novel Approaches to Multidrug-Resistant Infections in Cystic Fibrosis.
Murray TS; Stanley G; Koff JL
Clin Chest Med; 2022 Dec; 43(4):667-676. PubMed ID: 36344073
[TBL] [Abstract][Full Text] [Related]
15. The microbiome and emerging pathogens in cystic fibrosis and non-cystic fibrosis bronchiectasis.
Green H; Jones AM
Semin Respir Crit Care Med; 2015 Apr; 36(2):225-35. PubMed ID: 25826590
[TBL] [Abstract][Full Text] [Related]
16. Rationale and Prospects of Targeting Bacterial Two-component Systems for Antibacterial Treatment of Cystic Fibrosis Patients.
Velikova N; Wells JM
Curr Drug Targets; 2017; 18(6):687-695. PubMed ID: 26853320
[TBL] [Abstract][Full Text] [Related]
17. Emerging and unusual gram-negative infections in cystic fibrosis.
Davies JC; Rubin BK
Semin Respir Crit Care Med; 2007 Jun; 28(3):312-21. PubMed ID: 17562501
[TBL] [Abstract][Full Text] [Related]
18. [Emerging bacteria in cystic fibrosis and non-cystic fibrosis bronchiectasis from a microbiologist's perspective].
Menetrey Q; Dupont C; Chiron R; Marchandin H
Rev Mal Respir; 2020 Sep; 37(7):561-571. PubMed ID: 32684338
[TBL] [Abstract][Full Text] [Related]
19. Emerging bacterial pathogens and changing concepts of bacterial pathogenesis in cystic fibrosis.
Parkins MD; Floto RA
J Cyst Fibros; 2015 May; 14(3):293-304. PubMed ID: 25881770
[TBL] [Abstract][Full Text] [Related]
20. Increased Prevalence and Resistance of Important Pathogens Recovered from Respiratory Specimens of Cystic Fibrosis Patients During a Decade.
Raidt L; Idelevich EA; Dübbers A; Küster P; Drevinek P; Peters G; Kahl BC
Pediatr Infect Dis J; 2015 Jul; 34(7):700-5. PubMed ID: 25851069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
